ArticleOncotarget2015

In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma.

Ken Maes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.